Essex Investment Management’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-122,855
Closed -$4.9M 455
2020
Q4
$4.9M Sell
122,855
-22,280
-15% -$760K 0.61% 39
2020
Q3
$4.2M Buy
145,135
+4,766
+3% +$103K 0.6% 28
2020
Q2
$2.29M Sell
140,369
-684
-0.5% -$9.43K 0.38% 77
2020
Q1
$1.34M Sell
141,053
-70,729
-33% -$971K 0.27% 119
2019
Q4
$3.43M Buy
211,782
+9,943
+5% +$162K 0.42% 64
2019
Q3
$3.36M Sell
201,839
-22,784
-10% -$428K 0.48% 50
2019
Q2
$3.81M Sell
224,623
-77,059
-26% -$1.34M 0.52% 39
2019
Q1
$5.4M Sell
301,682
-6,503
-2% -$103K 0.8% 23
2018
Q4
$3.71M Buy
308,185
+32,788
+12% +$392K 0.58% 39
2018
Q3
$4.82M Sell
275,397
-20,331
-7% -$402K 0.57% 40
2018
Q2
$3.37M Buy
295,728
+67,182
+29% +$612K 0.42% 68
2018
Q1
$1.17M Sell
228,546
-25,550
-10% -$138K 0.15% 189
2017
Q4
$1.52M Buy
254,096
+169,341
+200% +$976K 0.2% 157
2017
Q3
$484K Buy
+84,755
New +$352K 0.07% 266

Other funds holding BLFS

Essex Investment Management's BLFS Position: Q1 2021 in Review

Essex Investment Management sold out of BioLife Solutions (BLFS) in Q1 2021, closing a stake of 122,855 shares — an estimated $4.9M sold.

Essex Investment Management first reported a position in BLFS in Q3 2017 and held it in 14 quarters. The position peaked at $5.4M in Q1 2019. 132 funds tracked by Wall St. Rank hold BLFS as of Q1 2021.

  • Essex Investment Management reported no remaining BioLife Solutions position as of Q1 2021 after selling out during the quarter.
  • Essex Investment Management sold 122,855 BioLife Solutions shares in Q1 2021, an estimated $4.9M.
  • Essex Investment Management first reported a position in BioLife Solutions in Q3 2017 and held it in 14 quarters.
  • Essex Investment Management's BioLife Solutions position peaked at $5.4M in Q1 2019.
  • 132 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2021.

Based on Essex Investment Management's 13F filing for Q1 2021, filed 12 May 2021.